Bacteremia
179
13
17
106
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
25 trials with published results (14%)
Research Maturity
106 completed trials (59% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.7%
21 terminated out of 179 trials
83.5%
-3.1% vs benchmark
22%
39 trials in Phase 3/4
24%
25 of 106 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 106 completed trials
Clinical Trials (179)
Impact of BacT/Alert® VIRTUO®, BioFire® Blood Culture Identification 2-BCID2 and REVEAL® (bioMérieux) on the Optimization of Antibiotic Therapy for Gram-negative Bacteremia in the ICU
Microbiology Operations & Time Optimization in Sepsis
Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia
Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients-Pilot Study
Epidemiology of Antimicrobial-use and Antimicrobial-resistant Infections in Four Hospitals in Thailand
Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge
Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use
Reducing Risk for Infective Endocarditis
Surveillance of AMR in DRC
Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia
T2 and SeptiCyte RAPID Duration Project
Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants.
Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)
Febrile Infants Swedish Study
Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia
Structural and Microbiological Characterization of Arterial Catheter Biofilm in ICU's Patients Using Optical Coherence Tomography
Temocillin vs Meropenem for the Targeted Treatment of Bacteraemia Resistant to Third Gen Cephalosporins
Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation
Virulence of Staphylococcus Lugdunensis in Severe Infections
Combined Rehabilitation and Nutritional Support vs. Standard Care in In-Hospital Endocarditis Treatment